NCT06203522View on ClinicalTrials.gov

Factors Associated With Successful Completion of MRI in Children Undergoing a Vigil Sedation With Dexmedetomidin

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2024

Conditions

Procedural SedationEEGMRI

Interventions

PROCEDURE

Data collection of successful completion of MRI

age, sex, autistic disorders, epilepsy, polyhandicap, non-autistic neurodevelopmental disorders, success of MRI procedure

Trial Locations (1)

57085

CHR Metz-Thionville/Hopital Mercy, Metz

All Listed Sponsors

lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT06203522 - Factors Associated With Successful Completion of MRI in Children Undergoing a Vigil Sedation With Dexmedetomidin | Biotech Hunter | Biotech Hunter